The Net Margin of Karyopharm Therapeutics Inc (KPTI) is -52.62%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -52.62% |
| 2023-12-31 | -97.99% |
| 2022-12-31 | -105.22% |
| 2021-12-31 | -59.15% |
| 2020-12-31 | -181.59% |
| 2019-12-31 | -488.02% |
| 2018-12-31 | -588.78% |
| 2017-12-31 | -8062.50% |
| 2016-12-31 | -54800.00% |
| 2015-12-31 | -39400.00% |